Try our beta test site

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

This study has been completed.
Sponsor:
Information provided by:
Amgen
ClinicalTrials.gov Identifier:
NCT00110929
First received: May 16, 2005
Last updated: April 22, 2010
Last verified: April 2010